Sign in to view content

Evaluation of 8 mg Intravitreal Aflibercept Injection for Neovascular Age-Related Macular Degeneration: Results from the Phase 2 CANDELA Study

W. Lloyd Clark, MD, FASRS

Video
Published 2022

Related

First Results From a Phase 1B Multiple-Dose Study of KSI-301: A Novel Anti-VEGF Antibody Biopolymer Conjugate (ABC) With Extended Durability
Pravin U. Dugel, MD
Annual Meeting Talks
2019
Update From an Ongoing Phase 1b/2 Open-label Clinical Trial Evaluating the Safety and Efficacy of AU-011 for the Treatment of Choroidal Melanoma
Ivana K. Kim, MD
Annual Meeting Talks
2020
Episode 201: AMD Drug Updates with Dr. Allen Ho, including Gene Therapy
Jayanth Sridhar, MD
Member Podcasts
2019

Category: wet AMD

See more